Great Diamond Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-9,723
Closed -$788K 231
2023
Q4
$788K Buy
9,723
+935
+11% +$72.8K 0.19% 106
2023
Q3
$659K Buy
8,788
+713
+9% +$54.8K 0.18% 114
2023
Q2
$622K Buy
8,075
+143
+2% +$11.4K 0.16% 115
2023
Q1
$658K Buy
+7,932
New +$657K 0.19% 106
2022
Q1
Sell
-3,121
Closed -$226K 220
2021
Q4
$226K Buy
3,121
+76
+2% +$5.24K 0.06% 204
2021
Q3
$212K Sell
3,045
-603
-17% -$42.4K 0.06% 197
2021
Q2
$251K Buy
3,648
+41
+1% +$2.74K 0.07% 178
2021
Q1
$233K Buy
3,607
+99
+3% +$6.38K 0.07% 177
2020
Q4
$204K Buy
+3,508
New +$212K 0.07% 177
2020
Q3
Sell
-2,858
Closed -$219K 163
2020
Q2
$219K Sell
2,858
-23
-0.8% -$1.76K 0.09% 134
2020
Q1
$215K Sell
2,881
-436
-13% -$30.1K 0.11% 119
2019
Q4
$215K Buy
+3,317
New +$216K 0.08% 146

Other funds holding GILD

Great Diamond Partners's GILD Position: Q1 2024 in Review

Great Diamond Partners sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 9,723 shares — an estimated $788K sold.

Great Diamond Partners first reported a position in GILD in Q4 2019 and held it in 12 quarters. The position peaked at $788K in Q4 2023. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Great Diamond Partners reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Great Diamond Partners sold 9,723 Gilead Sciences shares in Q1 2024, an estimated $788K.
  • Great Diamond Partners first reported a position in Gilead Sciences in Q4 2019 and held it in 12 quarters.
  • Great Diamond Partners's Gilead Sciences position peaked at $788K in Q4 2023.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Great Diamond Partners's 13F filing for Q1 2024, filed 8 May 2024.